يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Valverde C."', وقت الاستعلام: 0.63s تنقيح النتائج
  1. 1
    دورية أكاديمية

    وصف الملف: text

    العلاقة: https://eprints.whiterose.ac.uk/187113/3/s12885-022-09610-4.pdfTest; Pantaleo, MA, Heinrich, MC, Italiano, A et al. (11 more authors) (2022) A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor. BMC Cancer, 22 (1). 511. 511-. ISSN 1471-2407

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Pantaleo MA Division in Medical Oncology, IRCSS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Heinrich MC Portland VA Health Care System and Oregon Health and Science University, Knight Cancer Institute, Portland, Oregon, USA. Italiano A Institut Bergonie, Bordeaux, France. Valverde C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Schöffski P Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, and Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium. Grignani G Division of Medical Oncology, Candiolo Cancer Institute, TO, Italy, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: BMC Cancer;22; https://doi.org/10.1186/s12885-022-09610-4Test; Pantaleo MA, Heinrich MC, Italiano A, Valverde C, Schöffski P, Grignani G, et al. A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor. BMC Cancer. 2022 May 6;22:511.; https://hdl.handle.net/11351/8159Test; 000791786100010

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Serrano C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vivancos A, Matito J, Mancuso FM, Sansó M Cancer Genomics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. López-Pousa A Medical Oncology, Sant Pau University Hospital, Barcelona, Spain. Valverde C, Carles J Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Quiroga S Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Landolfi S Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Castro S, Dopazo C Servei de Cirurgia Oncològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. García-Valverde A, Rosell J Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Arribas J Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: BMC Cancer;20; https://doi.org/10.1186/s12885-020-6597-xTest; info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F01371; Serrano C, Vivancos A, López-Pousa A, Matito J, Mancuso FM, Valverde C, et al. Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors. BMC Cancer. 2020 Feb 5;20:99.; https://hdl.handle.net/11351/6303Test; 000521415500003